{"id":995699,"date":"2026-08-14T22:17:47","date_gmt":"2026-08-15T02:17:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/"},"modified":"2026-08-14T22:17:47","modified_gmt":"2026-08-15T02:17:47","slug":"capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/","title":{"rendered":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK and NEW ORLEANS<\/span>, Aug. 14, 2026<\/span> \/PRNewswire\/ —\u00a0Kahn Swick & Foti<\/a>, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc.<\/a>\u00a0(“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.<\/p>\n

\n

\n \"KSF\"\n <\/p>\n<\/p><\/div>\n

\n CLASS DEFINITION:<\/b>\u00a0The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California.<\/p>\n

Follow the link below to get more information and be contacted by a member of our team:<\/p>\n

\n https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-capr\/<\/a>\u00a0<\/p>\n

Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-833-538-3666 or via email (lewis.kahn@ksfcounsel.com<\/a>), or visit https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-capr\/<\/a>\u00a0to learn more.<\/p>\n

\n >>><\/b>
\n
\n CLICK HERE<\/b>
\n <\/a>
\n for more information<\/b>\n <\/p>\n

\n CASE DETAILS:<\/b>\u00a0According to the Complaint,\u00a0Capricor and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.\u00a0<\/p>\n

On July 27, 2026, pre-market, the U.S. Food and Drug Administration (“FDA”) published briefing documents ahead of its July 29 advisory committee meeting to review the Biologics License Application (“BLA”) for the Company’s lead product candidate, Deramiocel, finding that the Company made changes to the pre-specified statistical analysis plan (“SAP”) and that the final version “was not submitted to FDA for review prior to BLA submission and was not discussed and consequently not agreed upon.” Importantly, the final SAP was finalized just one day before the data was unblinded. The FDA disagreed with the changes made to the SAP, explaining that converting raw change to percent change and back again added unnecessary complexity and undermined accuracy, without scientific justification for doing so. As a result, the FDA stated that it “considers [Capricor’s] analyses based on the post-study SAP versions to be post-hoc and exploratory.” According to the briefing documents, the benefit-risk profile for deramiocel looked unfavorable given the lack of evidence supporting its effectiveness.<\/p>\n

On this news, Capricor’s stock fell $12.70, or 64%, to close at $7.00 per share on July 27, 2026, on unusually heavy trading volume<\/p>\n

The case is Nkamga v. Capricor Therapeutics, Inc., et al., <\/i>No. 3:26-cv-04385.<\/p>\n

\n WHAT TO DO?<\/b>\u00a0If you invested in Capricor and suffered a loss during the relevant time frame, you have until September 28, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.<\/p>\n

\n >>>To Learn More, Click <\/b>
\n
\n HERE<\/b>
\n <\/a>\n <\/p>\n

About Kahn Swick & Foti<\/a>, LLC<\/p>\n

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud<\/span> or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.<\/p>\n

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services<\/p>\n

To learn more about KSF, you may visit www.ksfcounsel.com<\/a>.<\/p>\n

\n >>>For More Information about the case, Click <\/b>
\n
\n HERE<\/b>
\n <\/a>\n <\/p>\n

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com<\/a>\u00a0
1-833-538-3666
1100 Poydras St., Suite 960
New Orleans, LA 70163<\/p>\n

CONNECT WITH US: Facebook<\/a>\u00a0|| Instagram<\/a>\u00a0|| YouTube<\/a>\u00a0|| TikTok<\/a>\u00a0|| LinkedIn<\/a><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit—contact-lewis-kahn-esq-at-kahn-swick–foti-llc-before-application-deadline-302852192.html<\/a><\/p>\n

SOURCE Kahn Swick & Foti, LLC<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK and NEW ORLEANS, Aug. 14, 2026 \/PRNewswire\/ —\u00a0Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc.\u00a0(“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit. CLASS DEFINITION:\u00a0The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-capr\/\u00a0 Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free … <\/p>\n

Continue reading “Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-995699","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCapricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK and NEW ORLEANS, Aug. 14, 2026 \/PRNewswire\/ —\u00a0Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc.\u00a0(“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit. CLASS DEFINITION:\u00a0The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-capr\/\u00a0 Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free … Continue reading "Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-15T02:17:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline\",\"datePublished\":\"2026-08-15T02:17:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/\"},\"wordCount\":636,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650245\\\/2025-PR-SEC.jpg?id=OA2888019\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/\",\"name\":\"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650245\\\/2025-PR-SEC.jpg?id=OA2888019\",\"datePublished\":\"2026-08-15T02:17:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650245\\\/2025-PR-SEC.jpg?id=OA2888019\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS650245\\\/2025-PR-SEC.jpg?id=OA2888019\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/","og_locale":"en_US","og_type":"article","og_title":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk","og_description":"PR Newswire NEW YORK and NEW ORLEANS, Aug. 14, 2026 \/PRNewswire\/ —\u00a0Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc.\u00a0(“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit. CLASS DEFINITION:\u00a0The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of California. Follow the link below to get more information and be contacted by a member of our team: https:\/\/www.ksfcounsel.com\/cases\/nasdaqgs-capr\/\u00a0 Capricor investors should contact KSF Managing Partner Lewis Kahn toll-free … Continue reading \"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-15T02:17:47+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline","datePublished":"2026-08-15T02:17:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/"},"wordCount":636,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/","name":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019","datePublished":"2026-08-15T02:17:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS650245\/2025-PR-SEC.jpg?id=OA2888019"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capricor-therapeutics-inc-notice-of-september-28-2026-application-deadline-for-class-action-lawsuit-contact-lewis-kahn-esq-at-kahn-swick-foti-llc-before-application-deadline-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=995699"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995699\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=995699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=995699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=995699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}